ロード中...
Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT
BACKGROUND: The clinical benefit of allergen-specific immunotherapy (AIT) involves induction of blocking antibodies. It is not clear if these antibodies function via steric hindrance alone or a combination of levels, avidities, and epitope specificities, and clinical outcome cannot be predicted. We...
保存先:
| 出版年: | Clin Transl Allergy |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174570/ https://ncbi.nlm.nih.gov/pubmed/30338052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-018-0226-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|